Prometheus Biosciences Raises $190M

Prometheus Biosciences Raises $190M

Recently, Prometheus Biosciences went public and raised $190M in its IPO. The company develops precision antibody therapies for IBD and related diseases. Read more here.

 

Leave a Reply